Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Carteolol hydrochloride
Drug ID BADD_D00373
Description A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Indications and Usage For the treatment of intraocular hypertension and chronic open-angle glaucoma
Marketing Status approved
ATC Code C07AA15; S01ED05
DrugBank ID DB00521
KEGG ID D00599
MeSH ID D002354
PubChem ID 40127
TTD Drug ID D03GCJ
NDC Product Code 43898-0104; 61314-238
UNII 4797W6I0T4
Synonyms Carteolol | OPC-1085 | OPC 1085 | OPC1085 | Carteolol Hydrochloride | Hydrochloride, Carteolol | Carteolol Monohydrochloride | Monohydrochloride, Carteolol
Chemical Information
Molecular Formula C16H25ClN2O3
CAS Registry Number 51781-21-6
SMILES CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Arrhythmia02.03.02.001--Not Available
Atrioventricular block02.03.01.002--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cardiac failure congestive02.05.01.002--Not Available
Cerebral ischaemia24.04.06.003; 17.08.01.005--
Cerebrovascular disorder24.03.05.002; 17.08.02.002--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Depression19.15.01.001--
Diplopia17.17.01.005; 06.02.06.002--Not Available
Eye irritation06.04.05.003--Not Available
Eyelid ptosis17.17.02.004; 06.05.01.002--Not Available
Headache17.14.01.001--
Hypersensitivity10.01.03.003--
Hypoaesthesia eye17.02.06.019; 06.01.01.007--Not Available
Hypoglycaemia05.06.03.001; 14.06.03.001--
Keratitis06.04.02.002--
Lacrimation increased06.08.02.004--
Nausea07.01.07.001--
Night blindness14.12.03.001; 06.02.10.010--
Oedema14.05.06.010; 08.01.07.006--Not Available
Palpitations02.11.04.012--
Photophobia06.01.01.004; 17.17.02.006--
Rash23.03.13.001--Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Vision blurred06.02.06.007; 17.17.01.010--
Visual impairment06.02.10.013--Not Available
Vital dye staining cornea present13.07.04.010--Not Available
Conjunctival hyperaemia06.04.01.004--Not Available
The 1th Page    1    Total 1 Pages